Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.

D'hooghe MB, Haentjens P, Nagels G, Garmyn M, De Keyser J.

Mult Scler. 2012 Apr;18(4):451-9. doi: 10.1177/1352458511423778. Epub 2011 Sep 27.

PMID:
21952096
2.

Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis.

D'hooghe MB, Haentjens P, Nagels G, D'Hooghe T, De Keyser J.

J Neurol. 2012 May;259(5):855-61. doi: 10.1007/s00415-011-6267-7. Epub 2011 Oct 13.

PMID:
21993617
3.

Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.

D'hooghe MB, Haentjens P, Nagels G, De Keyser J.

Eur J Neurol. 2012 Apr;19(4):616-24. doi: 10.1111/j.1468-1331.2011.03596.x. Epub 2011 Nov 25.

PMID:
22117611
4.

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.

Neurology. 2007 Oct 9;69(15):1498-507. Epub 2007 Aug 15.

PMID:
17699802
5.

Natural history of secondary-progressive multiple sclerosis.

Tremlett H, Yinshan Zhao, Devonshire V.

Mult Scler. 2008 Apr;14(3):314-24. doi: 10.1177/1352458507084264. Epub 2008 Jan 21.

PMID:
18208898
6.

Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.

McDowell TY, Amr S, Culpepper WJ, Langenberg P, Royal W, Bever C, Bradham DD.

Neuroepidemiology. 2011;37(1):52-7. doi: 10.1159/000329258. Epub 2011 Aug 5.

PMID:
21822026
7.

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

van Walderveen MA, Lycklama A Nijeholt GJ, Adèr HJ, Jongen PJ, Polman CH, Castelijns JA, Barkhof F.

Arch Neurol. 2001 Jan;58(1):76-81.

PMID:
11176939
8.
9.

Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.

Saeedi J, Rieckmann P, Yee I, Tremlett H; UBC MS clinic neurologists..

Mult Scler. 2012 Sep;18(9):1239-43. doi: 10.1177/1352458512436595. Epub 2012 Mar 1.

PMID:
22383230
10.

Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.

Simpson S Jr, Taylor B, Dwyer DE, Taylor J, Blizzard L, Ponsonby AL, Pittas F, Dwyer T, van der Mei I.

Mult Scler. 2012 Jun;18(6):799-806. doi: 10.1177/1352458511428081. Epub 2011 Nov 14.

PMID:
22084489
11.

The natural history of primary progressive multiple sclerosis.

Koch M, Kingwell E, Rieckmann P, Tremlett H.

Neurology. 2009 Dec 8;73(23):1996-2002. doi: 10.1212/WNL.0b013e3181c5b47f.

PMID:
19996074
12.

Self-reported levels of education and disability progression in multiple sclerosis.

D'hooghe MB, Haentjens P, Van Remoortel A, De Keyser J, Nagels G.

Acta Neurol Scand. 2016 Dec;134(6):414-419. doi: 10.1111/ane.12555. Epub 2016 Jan 6.

PMID:
27761897
13.

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.

Sola P, Mandrioli J, Simone AM, Ferraro D, Bedin R, Annecca R, Venneri MG, Nichelli PF, Merelli E.

Mult Scler. 2011 Mar;17(3):303-11. doi: 10.1177/1352458510386996. Epub 2010 Nov 15.

PMID:
21078694
14.

Corpus callosum index and long-term disability in multiple sclerosis patients.

Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N.

J Neurol. 2010 Aug;257(8):1256-64. doi: 10.1007/s00415-010-5503-x. Epub 2010 Mar 3.

PMID:
20198382
15.

Self-reported health promotion and disability progression in multiple sclerosis.

D'hooghe MB, Nagels G, De Keyser J, Haentjens P.

J Neurol Sci. 2013 Feb 15;325(1-2):120-6. doi: 10.1016/j.jns.2012.12.018. Epub 2013 Jan 4.

PMID:
23294496
16.

Relapses and progression of disability in multiple sclerosis.

Confavreux C, Vukusic S, Moreau T, Adeleine P.

N Engl J Med. 2000 Nov 16;343(20):1430-8.

17.

Progression in familial and nonfamilial MS.

Koch M, Uyttenboogaart M, Heerings M, Heersema D, Mostert J, De Keyser J.

Mult Scler. 2008 Apr;14(3):300-6. doi: 10.1177/1352458507084269. Epub 2008 Jan 21.

PMID:
18208881
18.

Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.

Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM.

Neurology. 2008 Mar 25;70(13 Pt 2):1084-91. doi: 10.1212/01.wnl.0000288179.86056.e1. Epub 2008 Jan 9.

PMID:
18184917
19.

Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.

Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1075-81. doi: 10.1136/jnnp-2012-304661. Epub 2013 Feb 5.

PMID:
23385850
20.

Natural history of multiple sclerosis: a unifying concept.

Confavreux C, Vukusic S.

Brain. 2006 Mar;129(Pt 3):606-16. Epub 2006 Jan 16.

PMID:
16415308

Supplemental Content

Support Center